These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 19999267
1. Triple-negative breast cancer in West Virginia. Abraham J, Flanagan M, Hazard H, Jubelirer S, Tirona MT, Vona-Davis L. W V Med J; 2009 Oct; 105 Spec No():54-9. PubMed ID: 19999267 [Abstract] [Full Text] [Related]
2. The changing pattern of early breast cancer and its primary management at CAMC. Jubelirer SJ, Smith JI, Gharib M. W V Med J; 1993 Oct; 89(10):442-4. PubMed ID: 8266681 [Abstract] [Full Text] [Related]
3. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A. Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228 [Abstract] [Full Text] [Related]
4. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening? Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM. Cancer Epidemiol Biomarkers Prev; 2004 Oct 01; 13(10):1569-73. PubMed ID: 15466971 [Abstract] [Full Text] [Related]
5. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening]. Ned Tijdschr Geneeskd; 2000 Jun 03; 144(23):1124-9. PubMed ID: 10876708 [Abstract] [Full Text] [Related]
6. Body weight correlates with mortality in early-stage breast cancer. Enger SM, Greif JM, Polikoff J, Press M. Arch Surg; 2004 Sep 03; 139(9):954-58; discussion 958-60. PubMed ID: 15381612 [Abstract] [Full Text] [Related]
7. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335 [Abstract] [Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS. Oncologist; 1996 Apr 01; 1(5):326-330. PubMed ID: 10388011 [Abstract] [Full Text] [Related]
9. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL. Cancer; 1998 Dec 15; 83(12):2502-8. PubMed ID: 9874455 [Abstract] [Full Text] [Related]
10. Breast cancer screening, incidence, and mortality in West Virginia. Khanna R, Bhanegaonkar A, Colsher P, Madhavan SS, Halverson J. W V Med J; 2009 Oct 15; 105 Spec No():24-32. PubMed ID: 19999262 [Abstract] [Full Text] [Related]
11. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):797-804. PubMed ID: 14967436 [Abstract] [Full Text] [Related]
12. Pattern of metastatic spread in triple-negative breast cancer. Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Breast Cancer Res Treat; 2009 May 01; 115(2):423-8. PubMed ID: 18543098 [Abstract] [Full Text] [Related]
13. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. Grabau D, Jensen MB, Rank F, Blichert-Toft M. APMIS; 2007 Jul 01; 115(7):828-37. PubMed ID: 17614850 [Abstract] [Full Text] [Related]
14. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY. Cancer; 2004 May 01; 100(9):1823-32. PubMed ID: 15112262 [Abstract] [Full Text] [Related]
15. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A. Cancer; 2004 Aug 15; 101(4):713-20. PubMed ID: 15305400 [Abstract] [Full Text] [Related]
16. Male breast cancer in the veterans affairs population: a comparative analysis. Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Cancer; 2007 Apr 15; 109(8):1471-7. PubMed ID: 17342768 [Abstract] [Full Text] [Related]
17. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR. Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542 [Abstract] [Full Text] [Related]
18. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Singh R, Hellman S, Heimann R. Cancer; 2004 May 01; 100(9):1807-13. PubMed ID: 15112260 [Abstract] [Full Text] [Related]
20. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ. Ann Surg Oncol; 2006 Nov 01; 13(11):1450-6. PubMed ID: 17009150 [Abstract] [Full Text] [Related] Page: [Next] [New Search]